One in two of us will develop cancer in our lifetime. Thanks to advances in diagnosis and treatment, though, more people are surviving cancer than ever. Will this trend continue and how close are we to finding a cure? That upward survival trend is likely to continue. But finding a cure? That's not so easy to answer, for a simple reason: cancer isn't one single disease but a collection of more than 200, each with unique features. Yet every cancer consists of a mass of abnormal cells, all originating from a single mutated cell that began to divide uncontrollably.
Cell division one cell dividing to produce two new ones - is essential for growing and maintaining our bodies. Cells that have become worn out or damaged must be replaced. This process is tightly controlled, so that cells are produced only when needed, and in the exact numbers and locations required. Cancer cells evade those controls and divide chaotically, while also eluding the back-up systems that suppress growth and weed out abnormally behaving cells. The result is a tumour.
Cancer cells acquire these characteristics through gene mutations. One important group of genes comprises the proto-oncogenes, which mutate to continuously produce a signal telling cancer cells to divide, becoming oncogenes. Turning off that oncogenic signal stops cancer cells dividing and can even kill them. That's the principle underpinning the concept of targeted cancer therapies, a treatment approach in which much progress has been made.
Targeted cancer therapies are more effective and have fewer side effects than traditional treatments such as chemotherapy and radiotherapy, and have now been in use for almost 50 years. The first were hormone therapies used for diseases such as breast and prostate cancer, whose growth depends on the hormones oestrogen and testosterone, respectively.
この記事は BBC Science Focus の New Year 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は BBC Science Focus の New Year 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
CHANGE THE (BODY) CLOCKS
Why the end of British Summer Time can be a wake-up call for our circadian health
ARE OCTOPUSES SENTIENT?
If you've watched the Netflix documentary My Octopus Teacher or been lucky enough to encounter an octopus in the wild, you'll know there's something special about them.
THE MEXICAN MOLE LIZARD
Imagine what would happen if an earthworm, a lizard, a snake and a mole went on a night out, had too much too much tequila and let their guard down.
Do we finally know how the Egyptian Pyramids were built?
A number of breakthrough studies are beginning to paint a picture of how these wonders of the world were built, but much of the story still remains a mystery...
ECLIPSES ON DEMAND
Inside an unassuming building, behind a damp car park in Antwerp, Belgium, scientists are teaching two spacecraft to be dance partners for a performance that will take place in front of the Sun.
How light's 'secret code' reveals the story of the cosmos
The starlight we can see tells us alot about the Universe, but it's the parts we can't see that contain the biggest revelations
An artificial heart inspired by plumbing
Mechanical circulation could revolutionise transplant design and reduce waiting lists
Major Stonehenge discovery deepens mystery around ancient monument
New findings suggest a key six-tonne stone came from over 450 miles north of the circle
THE UNEXPECTED RETURN OF PNEUMATIC TUBES
Once a pioneering technology that revolutionised deliveries, pneumatic tubes had all but disappeared. Now they're back and enjoying a resurgence
LIVING FOSSILS
FOR SOME CREATURES ALIVE TODAY TIME HAS ALMOST STOOD STILL. MEET THE 'LIVING FOSSILS' THAT GIVE US A GLIMPSE INTO LIFE IN THE DISTANT PAST
